BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10026413)

  • 1. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
    Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
    Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients.
    van Domburg PH; Willemsen MA; Rotteveel JJ; de Jong JG; Thijssen HO; Heerschap A; Cruysberg JR; Wanders RJ; Gabreëls FJ; Steijlen PM
    Neurology; 1999 Apr; 52(7):1345-52. PubMed ID: 10227616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of Sjögren-Larsson syndrome using enzymatic methods.
    Rizzo WB; Craft DA; Kelson TL; Bonnefont JP; Saudubray JM; Schulman JD; Black SH; Tabsh K; Dirocco M; Gardner RJ
    Prenat Diagn; 1994 Jul; 14(7):577-81. PubMed ID: 7971759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A very rare neurocutaneous disorder in 2 siblings: Sjögren-Larsson syndrome.
    Caglayan AO; Gumus H
    J Child Neurol; 2010 Aug; 25(8):1003-5. PubMed ID: 20142464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren-Larsson syndrome.
    Rizzo WB
    Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
    Rizzo WB; Carney G; Lin Z
    Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining the Sjögren-Larsson syndrome: atypical findings in three siblings and implications regarding diagnosis.
    Nigro JF; Rizzo WB; Esterly NB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):678-84. PubMed ID: 8912560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
    Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
    Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier detection for Sjögren-Larsson syndrome.
    Kelson TL; Craft DA; Rizzo WB
    J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
    Rizzo WB; Carney G
    Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
    Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
    J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sjogren-Larsson syndrome.
    Dutra LA; Braga-Neto P; Pedroso JL; Povoas Barsottini OG
    Adv Exp Med Biol; 2012; 724():344-50. PubMed ID: 22411255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A missense mutation in the FALDH gene identified in Sjögren-Larsson syndrome patients originating from the northern part of Sweden.
    Sillén A; Jagell S; Wadelius C
    Hum Genet; 1997 Aug; 100(2):201-3. PubMed ID: 9254849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.